All Articles

Oxford's Ludovic Phalippou has been honored for his critical research demystifying private markets. His work challenges performance myths and fee opacity.

Vantor and BAE Systems are building next-gen 20cm satellites. We analyze if this leap in resolution will truly redefine spatial intelligence or just raise the stakes.

A new board appointment reveals Serve Robotics' grand plan: to evolve from a delivery bot company into a foundational robotics infrastructure provider.

A routine press release from Pyxis Tankers about a safe transit reveals the untold story of navigating a post-war chokepoint and a new era of global risk.

A landmark deal brings VIZZ, a once-daily presbyopia treatment, to Australia and New Zealand, promising millions a life with less reliance on reading glasses.

With speakers from OpenAI and Google, The AI Conference focuses on practical strategies for operationalizing AI, moving the industry from promise to production.

Apollo Commercial Real Estate's large dividend has activated a special NYSE rule. We break down what the 'due bill' period means for shareholders and market mechanics.

State Street's new Nasdaq-100 ETF, QNDX, enters the ring with a rock-bottom fee, challenging titans like QQQ and reshaping core growth investing.

A deep dive into KNAV's WPO recognition reveals a new blueprint for success in professional services: global integration, AI-first strategy, and diverse leadership.

As automation floods the ad world, Bottle Rocket Media's handcrafted anniversary campaign argues that human creativity delivers an ROI that algorithms can't match.

REPROCELL's submission for Stemchymal® offers hope for an incurable disease and highlights Japan's accelerated regulatory path for regenerative medicine.

Beyond batteries, BLUETTI bets on open standards and AI partnerships to redefine energy independence. Is this the blueprint for the smart home grid?

As traditional insurance markets harden, companies are turning to captives. We explore why AM Best's upcoming briefing is a must-watch for modern risk managers.

A new media deal signals Perfect Game’s evolution from a scouting service to a content giant, reshaping talent discovery and value creation in youth sports.

A new partnership between Circadence and Scale AI aims to move AI from the lab to the front lines of cyber defense, promising a new era of autonomous readiness.

The mining giant’s dividend boost isn't just a shareholder reward; it's a bold signal of confidence in a supercharged copper market. What's the story here?

A new RNA therapy for obesity is advancing in trials. It promises to reduce harmful visceral fat, preserve muscle, and may only require a twice-yearly dose.

The Mexico Fund rewards investors with a major dividend hike, but a widening discount to its asset value and an activist's presence create a complex picture.

Bionano Genomics brings back OGM pioneer Dr. Alex Hastie as CSO. It's a strategic move to accelerate clinical adoption and restore investor confidence.

With quantum attacks looming, SEALSQ warns Europe's digital infrastructure is at risk. A deep dive into the race to build a quantum-proof future.